PB
Parallel Bio
OrganizationHeard in 1 episode across 1 show since Oct 2026
A biotechnology company developing high-throughput human biology and drug-discovery platforms, including organoid-based experimental systems.
Episodes
1
across 1 show
First heard
Oct 2026
Expert statements
2
2 positive
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
What experts have said about Parallel Bio
2 statements · 2 positive
Parallel Bio received FDA approval to bypass animal trials using organoid testing.
“they got FDA approval to skip animal trials.”
Open the episode · Recursive's $670M Bet on Self-Improving AI, Sonnet 5.5 Hits 70%, Elon Co-Leads Pentagon Push | EP #299Listen at 17:31
Parallel Bio’s organoid responses are more predictive of human drug interactions than animal tests.
“how those organoids react to different drugs and toxicity testing and so on, is actually more predictive of how those drugs will interact in real human bodies.”
Open the episode · Recursive's $670M Bet on Self-Improving AI, Sonnet 5.5 Hits 70%, Elon Co-Leads Pentagon Push | EP #299Listen at 18:00
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring Parallel Bio, newest first
